North Brunswick, NJ–(BUSINESS WIRE)—WellGen, Inc. (www.wellgen.com), a private biotechnology company that is discovering and developing proprietary medical foods using nutrigenomics technology, announced that Dr. Roddy Carter, president and chief executive officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference on Thursday, September 10, 2009 at 9:35 a.m. (Eastern Time) at the New York Palace Hotel in New York City.
03/03/10
Study Results Revealed
01/08/10
“About Harvest” Podcast Features WellGen
12/07/09
WellGen, Inc. and RFI Ingredients to Collaborate on Therapeutic Nutrition Opportunities
11/18/09
WellGen Recognized as Nutraceutical “Innovator” by Global Business Insights
04/07/09
Dr. Roddy Carter Named President and Chief Executive Officer
09/02/08
Robert J. Bertoldi Appointed Interim Chief Executive Officer of WellGen
02/12/08
WellGen Names Robert M. Hellauer as Chief Financial Officer
12/18/07
WellGen Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
08/24/10
Health Benefits from Tea: Perception vs. Reality
06/01/10
The Scientific & Medical Significance of Inflammation
03/17/10
Modulating Inflammation Provides Clinical Benefits for Diabetes
03/03/10
Study Results Revealed
10/01/09
Diabetes Connections
12/18/07
WellGen Names Nancy E. Rawson, Ph.D., Chief Scientific Officer